Literature DB >> 12853757

Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women.

Helen E Cejtin1, Lisa Jacobson, Gayle Springer, D Heather Watts, Alexandra Levine, Ruth Greenblatt, Kathryn Anastos, Howard L Minkoff, Leslie S Massad, Julie B Schmidt.   

Abstract

We compared the HIV-1-RNA and CD4 lymphocyte counts from users and non-users of hormonal contraception cross-sectionally upon entry into the Women's Interagency HIV Study, and again longitudinally. There did not appear to be an association between hormonal contraception use and HIV-1-RNA levels in our study. There was a small increase in CD4 cell counts among hormonal users of doubtful clinical significance.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12853757     DOI： 10.1097/00002030-200307250-00019

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  17 in total

1.  Virologic failure in an HIV-infected woman given desogestrel for excessive menstrual bleeding.

Authors:  Dario Cattaneo; Paola Meraviglia; Rosangela Beretta; Sara Baldelli; Valeria Cozzi; Greta Milani; Emilio Clementi
Journal:  Eur J Clin Pharmacol       Date:  2010-11-03       Impact factor: 2.953

Review 2.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

3.  Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.

Authors:  Charles S Morrison; Pai-Lien Chen; Immaculate Nankya; Anne Rinaldi; Barbara Van Der Pol; Yun-Rong Ma; Tsungai Chipato; Roy Mugerwa; Megan Dunbar; Eric Arts; Robert A Salata
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

4.  Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.

Authors:  Jessica L Castilho; Cathy A Jenkins; Bryan E Shepherd; Sally S Bebawy; Megan Turner; Timothy R Sterling; Vlada V Melekhin
Journal:  J Womens Health (Larchmt)       Date:  2015-03-09       Impact factor: 2.681

Review 5.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

Review 6.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

7.  Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative.

Authors:  Elizabeth M Stringer; Mark Giganti; Rosalind J Carter; Wafaa El-Sadr; Elaine J Abrams; Jeffrey Sa Stringer
Journal:  AIDS       Date:  2009-11       Impact factor: 4.177

8.  HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial.

Authors:  Elizabeth M Stringer; Jens Levy; Moses Sinkala; Benjamin H Chi; Inutu Matongo; Namwinga Chintu; Jeffrey S A Stringer
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

9.  Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.

Authors:  D Heather Watts; Jeong-Gun Park; Susan E Cohn; Song Yu; Jane Hitti; Alice Stek; Pamela A Clax; Laila Muderspach; Juan J L Lertora
Journal:  Contraception       Date:  2007-12-21       Impact factor: 3.375

Review 10.  Hormonal contraception and HIV disease progression.

Authors:  Elizabeth Stringer; Erik Antonsen
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.